| Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals LF Vendruscolo, D Estey, V Goodell, LG Macshane, ML Logrip, ... The Journal of clinical investigation 125 (8), 3193-3197, 2015 | 211 | 2015 |
| Tolerance to alcohol: A critical yet understudied factor in alcohol addiction SK Elvig, MA McGinn, C Smith, MA Arends, GF Koob, LF Vendruscolo Pharmacology Biochemistry and Behavior 204, 173155, 2021 | 50 | 2021 |
| The affective dimension of pain as a risk factor for drug and alcohol addiction DM LeBlanc, MA McGinn, CA Itoga, S Edwards Alcohol 49 (8), 803-809, 2015 | 40 | 2015 |
| Neurobiological correlates of pain avoidance-like behavior in morphine-dependent and non-dependent rats AR Pahng, RI Paulsen, MA McGinn, KN Edwards, S Edwards Neuroscience 366, 1-14, 2017 | 31 | 2017 |
| A novel role for the endocannabinoid system in ameliorating motivation for alcohol drinking and negative behavioral affect after traumatic brain injury in rats EA Fucich, JP Mayeux, MA McGinn, NW Gilpin, S Edwards, PE Molina Journal of neurotrauma 36 (11), 1847-1855, 2019 | 27 | 2019 |
| Glucocorticoid receptor modulators decrease alcohol self-administration in male rats MA McGinn, BJ Tunstall, JE Schlosburg, A Gregory-Flores, O George, ... Neuropharmacology 188, 108510, 2021 | 25 | 2021 |
| The prefrontal cortex as a critical gate of negative affect and motivation in alcohol use disorder AR Pahng, MA McGinn, RI Paulsen, S Edwards Current opinion in behavioral sciences 13, 139-143, 2017 | 21 | 2017 |
| Spironolactone as a potential new pharmacotherapy for alcohol use disorder: convergent evidence from rodent and human studies M Farokhnia, CT Rentsch, V Chuong, MA McGinn, SK Elvig, EA Douglass, ... Molecular psychiatry 27 (11), 4642-4652, 2022 | 18 | 2022 |
| Chronic inflammatory pain alters alcohol-regulated frontocortical signaling and associations between alcohol drinking and thermal sensitivity MA McGinn, KN Edwards, S Edwards Neurobiology of pain 8, 100052, 2020 | 17 | 2020 |
| Predator odor stress blunts alcohol conditioned aversion AL Schreiber, MA McGinn, S Edwards, NW Gilpin Neuropharmacology 144, 82-90, 2019 | 14 | 2019 |
| Withdrawal from chronic nicotine exposure produces region‐specific tolerance to alcohol‐stimulated GluA1 phosphorylation MA McGinn, RI Paulsen, CA Itoga, MA Farooq, JE Reppel, KN Edwards, ... Alcoholism: Clinical and Experimental Research 40 (12), 2537-2547, 2016 | 14 | 2016 |
| Impaired hypothalamic feedback dysregulates brain glucocorticoid signaling in genetically‐selected Marchigian Sardinian alcohol‐preferring rats LA Natividad, MQ Steinman, MA McGinn, S Sureshchandra, TM Kerr, ... Addiction biology 26 (3), e12978, 2021 | 8 | 2021 |
| Dysregulation of c-Jun N-terminal kinase phosphorylation in alcohol dependence AR Pahng, RI Paulsen, MA McGinn, MA Farooq, KN Edwards, S Edwards Alcohol 75, 11-18, 2019 | 8 | 2019 |
| Pathophysiology of affective disorders: functional interaction of stress hormones and hippocampal excitation MA McGinn, AR Pahng Journal of Neurophysiology 117 (2), 477-479, 2017 | 5 | 2017 |
| Drug addiction co-morbidity with alcohol: Neurobiological insights MA McGinn, CB Pantazis, BJ Tunstall, RCN Marchette, ER Carlson, ... International review of neurobiology 157, 409-472, 2021 | 4 | 2021 |
| The mineralocorticoid receptor: an emerging pharmacotherapeutic target for alcohol use disorder? AH Lékó, MA McGinn, M Farokhnia ACS Chemical Neuroscience 13 (13), 1832-1834, 2022 | 2 | 2022 |
| Glucocorticoid Receptor‐Dependent Gene Expression in the Central Amygdala of Alcohol‐Dependent Animals MA McGinn, K Edwards, S Edwards The FASEB Journal 32, 878.7-878.7, 2018 | 1 | 2018 |
| Inhibition of endocannabinoid degradation improves behavioral effects of traumatic brain injury that are associated with amygdalar hyperexcitability in rats EA Fucich, JP Mayeux, MA McGinn, PJ Stoulig, LM Romero, S Edwards, ... The FASEB Journal 32, 877.5-877.5, 2018 | 1 | 2018 |
| Converging Evidence from Rodent and Human Studies on the Role of Spironolactone as a Potential Pharmacotherapy for Alcohol Use Disorder M Farokhnia, CT Rentsch, V Chuong, MA McGinn, SK Elvig, EA Douglass, ... Alcohol 109, 83-84, 2023 | | 2023 |
| Converging evidence from human pharmacoepidemiology and rodent psychopharmacology studies on the role of spironolactone as a potential pharmacotherapy for alcohol use disorder M Farokhnia, C Rentsch, V Chuong, A McGinn, S Elvig, E Douglass, ... PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 31, 348-349, 2022 | | 2022 |
